Publications by authors named "Gregory A Otterson"

100Publications

Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer.

Lung Cancer 2020 08 21;146:36-41. Epub 2020 May 21.

The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2020.05.021DOI Listing
August 2020

Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical Considerations.

Clin Lung Cancer 2020 Jul 25;21(4):e265-e269. Epub 2020 Feb 25.

Division of Thoracic Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH; Ohio State University Comprehensive Cancer Center- James and Solove Research Institute, Columbus, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.02.016DOI Listing
July 2020

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers.

J Cancer Res Clin Oncol 2019 Oct 31;145(10):2541-2546. Epub 2019 Jul 31.

Division of Medical Oncology, Department of Internal Medicine, Ohio State University Wexner Medical Center, 320 W 10th Ave, A450B Starling Loving Hall, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-019-02982-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751277PMC
October 2019

Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer.

Lung Cancer 2019 08 17;134:167-173. Epub 2019 Jun 17.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.06.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194132PMC
August 2019

Immunotherapy in inoperable stage III non-small cell lung cancer: a review.

Drugs Context 2019 17;8:212578. Epub 2019 Jun 17.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7573/dic.212578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586171PMC
June 2019

Agents to treat mutant lung cancer.

Drugs Context 2019 13;8:212566. Epub 2019 Mar 13.

Division of Medical Oncology, Department of Internal Medicine, The James Cancer Center and Solove Research Institute, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7573/dic.212566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419923PMC
March 2019

Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.

Int J Cancer 2019 11 13;145(9):2418-2426. Epub 2019 Apr 13.

Department of Human & Molecular Genetics, Herbert Wertheim College of Medicine, The Florida International University, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32279DOI Listing
November 2019

Do toxicity patterns vary between programmed death-1 and programmed death ligand-1 inhibitors?

J Thorac Dis 2018 Nov;10(Suppl 33):S4069-S4072

Division of Medical Oncology, Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.09.102DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297519PMC
November 2018

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database.

Radiat Oncol 2018 Oct 5;13(1):196. Epub 2018 Oct 5.

Department of Radiation Oncology, at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, 460 W. 10th Avenue, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
https://ro-journal.biomedcentral.com/articles/10.1186/s13014
Publisher Site
http://dx.doi.org/10.1186/s13014-018-1142-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173899PMC
October 2018

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer.

Clin Lung Cancer 2018 11 22;19(6):e893-e900. Epub 2018 Aug 22.

Division of Medical Oncology, Ohio State University Wexner Medical Center, James Cancer Hospital and Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.08.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193681PMC
November 2018

Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma.

J Thorac Oncol 2018 08 24;13(8):1204-1212. Epub 2018 Apr 24.

Division of Medical Oncology, Department of Internal Medicine, Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193686PMC
August 2018

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

N Engl J Med 2018 May 16;378(22):2093-2104. Epub 2018 Apr 16.

From Memorial Sloan Kettering Cancer Center Hospital, New York (M.D.H.); Prof. Dr. Ion Chiricuta Institute of Oncology and Universitatea de Medicina si Farmacie Iuliu Hatieganu, Cluj-Napoca, Romania (T.-E.C.); Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland (A.P.); Seoul National University Bundang Hospital, Seoul, South Korea (J.S.L.); Ohio State University, Columbus (G.A.O.); Hôpital Sainte Musse, Toulon, France (C.A.-V.); Ospedale Santa Maria della Misericordia, Perugia, Italy (E.M.); First Department of Oncology, Metropolitan Hospital, Athens, Greece (H.L.); Antoni van Leeuwenhoek Ziekenhuis, Amsterdam (S.B.); Fundación Arturo López Pérez, Santiago, Chile (P.S.); Fox Chase Cancer Center, Philadelphia (H.B.); Winship Cancer Institute, Emory University, Atlanta (S.S.R.); Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany (M.R.); Princess Alexandra Hospital, Brisbane, QLD, Australia (K.J.O.); Bristol-Myers Squibb, Princeton, NJ (W.J.G., G.G., H.C., J.S., P.B., D.H., Y.F., F.N.); and Hospital Universitario 12 de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, and CiberOnc, Madrid (L.P.-A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1801946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193684PMC
May 2018

Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer.

Curr Pharmacol Rep 2017 Dec 14;3(6):360-373. Epub 2017 Oct 14.

Arthur G. James Cancer Hospital Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831502PMC
http://dx.doi.org/10.1007/s40495-017-0110-5DOI Listing
December 2017

Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.

Int J Radiat Oncol Biol Phys 2018 03 23;100(3):748-755. Epub 2017 Nov 23.

Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193687PMC
March 2018

Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy.

J Thorac Oncol 2018 02 5;13(2):e17-e19. Epub 2017 Oct 5.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864173276
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2017.09.1962DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910030PMC
February 2018

New treatment options and challenges for patients with anaplastic lymphoma kinase-positive non-small cell lung cancer with brain metastases.

J Thorac Dis 2017 Feb;9(2):E158-E161

James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.02.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334100PMC
February 2017

Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with Anti-PD-1/PD-L1 Antibodies.

J Thorac Oncol 2016 11 3;11(11):1927-1939. Epub 2016 Aug 3.

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.07.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086375PMC
November 2016

Incorporation of Antiangiogenic Therapy Into the Non-Small-Cell Lung Cancer Paradigm.

Clin Lung Cancer 2016 11 8;17(6):493-506. Epub 2016 Jun 8.

Division of Medical Oncology, Department of Internal Medicine, James Comprehensive Cancer Center and Solove Research Institute at The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.05.020DOI Listing
November 2016

Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 01 30;12(1):145-151. Epub 2016 Sep 30.

Birmingham Veterans Administration Hospital, Birmingham, Alabama; University of Alabama-Birmingham Comprehensive Cancer Center, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249761PMC
January 2017

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

J Natl Compr Canc Netw 2016 07;14(7):825-36

From The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; City of Hope Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0087DOI Listing
July 2016

Lung cancer exosomes as drivers of epithelial mesenchymal transition.

Oncotarget 2016 Aug;7(34):54852-54866

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342386PMC
August 2016

Rad51C-ATXN7 fusion gene expression in colorectal tumors.

Mol Cancer 2016 06 13;15(1):47. Epub 2016 Jun 13.

Comprehensive Cancer Center, the Ohio State University College of Medicine and Public Health, Columbus, Ohio, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-016-0527-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906819PMC
June 2016

Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations.

Case Rep Pulmonol 2015 23;2015:283875. Epub 2015 Aug 23.

Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/283875DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561101PMC
September 2015

Non-Small Cell Lung Cancer, Version 6.2015.

J Natl Compr Canc Netw 2015 May;13(5):515-24

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Washington/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0071DOI Listing
May 2015

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).

J Clin Oncol 2015 May 2;33(15):1660-5. Epub 2015 Mar 2.

Neal E. Ready and Jeffrey Crawford, Duke University Medical Center; Herbert H. Pang and Lin Gu, Alliance Statistics and Data Center, Duke University Medical Center, Durham; Antonius A. Miller, Wake Forest University Medical Center, Winston Salem, NC; Gregory A. Otterson, Ohio State University Medical Center, Columbus, OH; Sachdev P. Thomas, Illinois Oncology Research Association Community Clinical Oncology Program, Illinois Cancer Care, Peoria; Everett E. Vokes, University of Chicago, Chicago, IL; Maria Baggstrom, Washington University School of Medicine, St Louis, MO; Gregory A. Masters, Christiana Healthcare Services, Christiana Hospital, Newark, DE; Stephen L. Graziano and Jeffrey Bogart, State University of New York Upstate Medical University, Syracuse, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.3105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429175PMC
May 2015

Overexpression of Rad51C splice variants in colorectal tumors.

Oncotarget 2015 Apr;6(11):8777-87

Comprehensive Cancer Center, The Ohio State University College of Medicine and Public Health, Columbus, Ohio, U.S.A.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496183PMC
http://dx.doi.org/10.18632/oncotarget.3209DOI Listing
April 2015

Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.

J Natl Compr Canc Netw 2015 Jan;13(1):23-34; quiz 34

From University of Washington/Seattle Cancer Care Alliance; University of Michigan Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Dana-Farber/Brigham and Women's Cancer Center; Moffitt Cancer Center; Fox Chase Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Stanford Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Vanderbilt-Ingram Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Huntsman Cancer Institute at the University of Utah; Roswell Park Cancer Institute; City of Hope Comprehensive Cancer Center; University of Colorado Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Memorial Sloan Kettering Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0006DOI Listing
January 2015

Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancer.

Front Oncol 2014 19;4:368. Epub 2014 Dec 19.

Comprehensive Cancer Center, The Ohio State University College of Medicine and Public Health , Columbus, OH , USA ; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University College of Medicine and Public Health , Columbus, OH , USA ; Department of Pharmacology, The Ohio State University College of Medicine and Public Health , Columbus, OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00368DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271581PMC
January 2015

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.

J Thorac Oncol 2014 Feb;9(2):214-21

*Department of Thoracic Oncology, Massachusetts General Hospital, Boston, Massachusetts; †Department of Oncology, Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina; ‡Department of Oncology, Ohio State University Medical Center, Columbus, Ohio; §Department of Oncology, University of North Carolina, Chapel Hill, North Carolina; ‖Department of Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, Kinston Medical Specialists, P.A., Kinston, North Carolina; #Department of Oncology, University of Chicago, Chicago, Illinois; and **Department of Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284815PMC
February 2014

Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors.

Diagn Pathol 2013 Dec 10;8:201. Epub 2013 Dec 10.

Department of Pathology, The Wexner Medical Center at the Ohio State University, 410 W, 10th Avenue, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1746-1596-8-201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933389PMC
December 2013

High-dose pemetrexed in combination with high-dose crizotinib for the treatment of refractory CNS metastases in ALK-rearranged non-small-cell lung cancer.

J Thorac Oncol 2013 Jan;8(1):e3-5

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182762d20DOI Listing
January 2013

Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.

Cancer 2013 Feb 28;119(4):847-53. Epub 2012 Sep 28.

The Ohio State University College of Public Health and the Comprehensive Cancer Center, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27824DOI Listing
February 2013

Photodynamic therapy (PDT) may provide effective palliation in the treatment of primary tracheal carcinoma: a small case series.

Photomed Laser Surg 2012 Nov 24;30(11):668-71. Epub 2012 Sep 24.

The Ohio State University-James Cancer Hospital, 320 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/pho.2012.3293DOI Listing
November 2012

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.

Invest New Drugs 2013 Jun 31;31(3):685-95. Epub 2012 Jul 31.

Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University and The Comprehensive Cancer Center, A454 Starling-Loving Hall, 320 West 10th Ave, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-012-9863-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646991PMC
June 2013

Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer.

J Oncol 2012 30;2012:957437. Epub 2012 Apr 30.

Department of Pathology, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/957437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350860PMC
August 2012

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

Lung Cancer 2012 Jun 22;76(3):393-6. Epub 2011 Dec 22.

Department of Medicine, Division of Hematology Oncology, University of California, San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.11.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778731PMC
June 2012

Romidepsin: a novel histone deacetylase inhibitor for cancer.

Expert Opin Investig Drugs 2011 Aug 24;20(8):1151-8. Epub 2011 Jun 24.

The Ohio State University, Comprehensive Cancer Center, Department of Internal Medicine, Columbus, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2011.594437DOI Listing
August 2011

The search for an optimal DNA, RNA, and protein detection by in situ hybridization, immunohistochemistry, and solution-based methods.

Methods 2010 Dec 1;52(4):281-6. Epub 2010 Oct 1.

Divisions of Hematology & Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, College of Medicine, The Ohio State University, 320 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2010.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375896PMC
December 2010

Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer.

Lung Cancer 2010 Dec;70(3):233-46

Department of Internal Medicine, Division of Hematology-Oncology, The Ohio State University Medical Center, 320 West 10th Avenue, Columbus 43210, OH, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2010.08.018DOI Listing
December 2010

Small cell lung cancer in never smokers: report of two cases.

J Thorac Oncol 2010 May;5(5):747-8

Division of Hematology, Oncology, and Transplantation, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181d6e124DOI Listing
May 2010

MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer.

Biochem Biophys Res Commun 2009 Oct 3;388(3):483-9. Epub 2009 Aug 3.

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, DHLRI, 473 West 12th Avenue, Room 201, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2009.07.143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824514PMC
October 2009

Pulmonary neuroendocrine/carcinoid tumors: a review article.

Cancer 2009 Oct;115(19):4434-41

Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24498DOI Listing
October 2009

Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.

Cancer Chemother Pharmacol 2010 Jan;65(2):319-24

Department of Medicine, The Ohio State University, Columbus, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1036-3DOI Listing
January 2010

MicroRNAs in the pathogenesis of Lung Cancer.

J Thorac Oncol 2009 Aug;4(8):1028-34

The Ohio State University Medical Center, Division of Hematology and Oncology, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181a99c77DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723999PMC
August 2009